Healthcare & Life Sciences
Gemphire Therapeutics
United Statesgemphiretherapeutics.com
Gemphire Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
series-b
series-b
Stage
1
Investors
About Gemphire Therapeutics
Gemphire Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Gemphire Therapeutics is a biopharmaceutical company focused on developing treatments for Painful Diabetic Neuropathy (PDN) and Alzheimer's disease, notably after merging with NeuroBo Pharmaceuticals in 2019.
Explore Gemphire Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.